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Hyperoxaluria corresponds to an excessive urinary excretion of oxalate anions. Hyper-
oxaluria may be associated with the presence of calcium oxalate monohydrate crystals in
kidney tissue and in some cases may lead to renal failure. In this contribution, a set of ten
kidney biopsies corresponding to patients affected by hyperoxaluria from various origins
such as primary hyperoxaluria or gastrointestinal disease has been investigated through
mFourier transform infrared (FTIR) spectroscopy and Field Emission scanning Electron
Microscopy (FE-SEM). The complete set of results indicates that if the deposits are mainly
constituted of calcium oxalate monohydrate, some of them are made of calcium phosphate
apatite, an observation which underlines the use of physicochemical techniques instead of
the classical staining procedures. Moreover, FE-SEM observations clearly show a diversity
of the crystallite morphology. Such diversity suggests changes in the composition of the
milieu along the nephron and different interactions between calcium oxalate crystals and
ions or macromolecules such as osteopontin and/or TammeHorsfall protein for example.
This approach may help the clinician to understand more deeply the biochemical pa-
rameters which determine the formation of calcium oxalate monohydrate crystallites in
kidney tissue and deﬁne the corresponding etiology.
© 2016 Published by Elsevier Masson SAS on behalf of Académie des sciences. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Hyperoxaluria is a metabolic disorder that may lead in
some cases to end-stage renal failure and is deﬁned as the
excessive urinary excretion of oxalate anions (greater thanPMC Univ Paris 06,
a Matiere Condensee
France.
Bazin).
S on behalf of Académie de
).50mg/1.73m2 per 24 h) [1]. This disease is characterized by
calcium oxalate deposition ﬁrst in kidney tissue and in the
case of severe decrease of the glomerular ﬁltration rate in
other tissues including bones, heart and vessels. Hyper-
oxaluria constitutes a multifactorial disease and among the
different aetiologies related to hyperoxaluria, we can quote
lethal genetic disorders of the glyoxylate metabolism (the
primary hyperoxalurias) [2e8], gastrointestinal diseases
including cancers, inﬂammatory bowel diseases and theirs sciences. This is an open access article under the CC BY-NC-ND license
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cystic ﬁbrosis, and overconsumption/production of oxalate
or its precursors from exogenous sources. Bariatric surgery
[10] and intestinal lymphangiectasia [11] may also lead to
hyperoxaluria.
Primary hyperoxalurias (PHs) are related to inborn er-
rors in the metabolism of glyoxylate and oxalate [2e8] and
lead to recurrent nephrolithiasis, nephrocalcinosis, sys-
temic oxalosis, and renal failure. Aside from combined
liver/kidney transplantation, no curative treatment exists.
Calcium oxalate monohydrate (COM) kidney stones related
to PH exhibit a peculiarmorphology at themacroscopic and
the mesoscopic scale [12e14]. Crystallite morphologies
play deﬁnitely a major role in the classiﬁcation of kidney
stones [13,15e17] and thus in the deﬁnition of their
etiology.
This contribution is devoted to the characterization of
ectopic calciﬁcations present in kidney of patients suffering
from severe hyperoxaluria [18e21]. If ectopic calciﬁcations
can be probed using a usual procedure based on staining, it
is at the cost of limited information on their chemical na-
ture [22e24]. To go beyond this drastic limitation, different
techniques can be used [25e28]. Here, we have selected
mFourier Transform Infra-Red (FTIR) spectroscopy [29e36]
and Field Emission Scanning Electron Microscopy (FE-
SEM) [37e39] in order to characterize the crystalline pha-
ses forming abnormal deposits and to describe precisely
their topology and structure.
2. Material and methods
Ten kidney biopsies were investigated (Table 1). The
biological samples came from Tenon Hospital (Paris,
France). For tissue embedded in parafﬁn, the parafﬁn was
chemically removed in order to improve the crystal
detection under the microscope. Each sample was only
named with a study number, without indication of the
name of the patient or potential identiﬁcation data.
2.1. mFTIR microspectroscopy
The starting point of this investigation was given by
mFTIR data in order to localize and determine the chemical
nature of the pathological deposits present in kidney bi-
opsy [39]. To fullﬁl IR reﬂexion, kidney biopsies were
deposited on low-e microscope slides (MirrIR, KevleyTable 1
Etiology corresponding to the selected kidney biopsies.
Sample Etiology
B274 Primary hyperoxaluria diagnosed after kidney
transplantation
B279 Excessive consumption of rhubarb
B292 Ethylene glycol intoxication
B305 Nephrocalcinosis after kidney transplantation
B317 Nephrocalcinosis after kidney transplantation
B329 Primary hyperoxaluria
B364 Cystic ﬁbrosis
B379 Bariatric surgery
B380 Stomach cancer
B386 Nephrocalcinosis after kidney transplantationTechnologies, Tienta Sciences, Indianapolis). FTIR hyper-
spectral images were recorded with a Spectrum Spotlight
300 FTIR imaging system (Perkin Elmer Life Sciences,
France), with a spatial resolution of 6.25 mm and a spectral
resolution of 8 cm1. Each spectral image, covering a sub-
stantial part of the biopsy, consisted of about 30 000
spectra.
IR microspectroscopy was also performed on an
IN10MXmicroscope (Thermo Scientiﬁc) for recording large
maps. All spectra were collected in ultrafast mode using a
50 mm  50 mm aperture. The spectra were collected in the
4000e800 cm1 mid-IR range at a resolution of 16 cm1
with one spectrum per pixel. Data analysis of IR spectra and
chemical images was performed using OMNIC software
(Thermo Scientiﬁc).2.2. Field Emission Scanning Electron Microscopy
A Zeiss SUPRA55-VP SEM was used for observation of
the microstructure [37,39]. This ﬁeld-emission “gun” mi-
croscope (FE-SEM) operates at 0.5e30 kV. High-resolution
observations were obtained by using 2 secondary electron
detectors: an in-lens SE detector and an Everhart-
Thornley SE detector. Measurements were taken at low
voltage (between 0.5 and 2 kV) without the usual deposits
of carbon at the surface of the sample. Energy Dispersive
X-ray (EDX) experiments can also be performed. In order
to perform Ca cartography, the FE-SEM was operated at
12 kV.
3. Results and discussion
Quite recently, calcium oxalate compounds have been
the subject of different publications [40e44] which have
been dedicated to the insertion of heavy elements in their
structure [45] or to their synthesis [46]. From a chemical
point of view, the synthesis of amorphous COM can be
considered a breakthrough in the chemistry of calcium
oxalate compounds [47]. Among the different in-
vestigations we can quote the study of the adhesion and
internalization between African green monkey kidney
epithelial cells (before and after oxidative damage by
hydrogen peroxide) and COM nanocrystals [48] or the
internalization into MDCK renal tubular cells of COM
crystals by endolysosomes [49]. As underlined by H. Shir-
aga et al. [50], although normal urine is frequently super-
saturated with respect to calcium oxalate, most humans do
not form stones. Inhibitors are among the multiple factors
that may inﬂuence the complex process of urinary stone
formation.
Regarding diseases related to calcium oxalate crystal
deposition that lead to a signiﬁcant loss of the kidney
function, prevalent attention has been paid to hyper-
oxaluria. Although numerous excellent investigations exist
[9,10,51e53], little attention has been paid to the crystallite
morphology of COM ectopic calciﬁcation. This justiﬁes the
efforts undertaken here to describe the topology of these
abnormal mineral deposits as well as their spatial reparti-
tion. In order to do so, the ﬁrst step is to localize the COM
deposits in the kidney biopsy.
Fig. 1. Graft kidney in a patient suffering from primary hyperoxaluria (B274). (A) Optical photography, and (B) Spatial distribution of COM deposits in the biopsy
as given by the intensity of the infrared spectrum (C) at 780 cm1.
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ciﬁcations present in kidney [54e65]. Fig. 1 shows an
example of FTIR data which can be gathered on a kidney
biopsy (Fig. 1A). The precise identiﬁcation of pathological
deposits is straightforward through the position of typical
IR absorption bands. In fact, a typical tissue spectrum has
two primary features due to proteins, the amide I
(1600e1700 cm1) and amide II (1500e1560 cm1) bands,
which arise primarily from the CeO and CeN stretching
vibrations of the peptide backbone, respectively
[30,66,67]. Far from these biological contributions, it is
generally the IR absorption band positioned at 780 cm1
which is selected to obtain the spatial distribution of COM
crystallites. This typical band corresponds to the d(OeC]
O) vibration.
As evidenced in Fig. 2, even small biopsy samples may
be analyzed through this approach and provide useful in-
formation (Fig. 2D and E). At this point it is worth under-
lining that mFTIR is capable of identifying different kinds of
chemical phases in the same biopsy. It is the case of the
biopsy B317 for which COM (Fig. 2G and H) as well as cal-
cium phosphate apatite (Fig. 2I and J) are present.
The second step of this investigation is given by obser-
vations at different magniﬁcations through last generation
FE-SEM. On the very same sample on which FTIR mea-
surements have been performed, FE-SEM offers the op-
portunity to describe at the submicrometer scale the
topology of mineral deposits present in biopsy. Such a
combined approach which mixed chemical identiﬁcation(through FTIR microspectroscopy) and topology descrip-
tion (through FE-SEM) both at the cellular level is exem-
pliﬁed in Fig. 3. Details regarding the crystallite
morphology can be obtained through observations at high
magniﬁcation.
Similar data have been gathered for the different kidney
biopsies selected in this study as shown in Fig. 4 (for the
biopsy B292) and Fig. 5 (for the biopsy B317). As previously
underlined, all the deposits are not made of COM for the
biopsy B317 and the red star in Fig. 5 indicate the location of
a deposit made of calcium phosphate apatite. Of notice is
that the precise description of the crystallite morphology
can be obtained even for small kidney biopsies.
Even if the number of samples is limited, the complete
set of observations through FE-SEM indicates that COM
deposits may exist with very different topologies whatever
the etiology of hyperoxaluria is. This diversity is clearly
visible in Fig. 3 (B274) which corresponds to genetic
hyperoxaluria, in Fig. 4 (B292) which corresponds to
hyperoxaluria related to the consumption of ethylene gly-
col or in Fig. 5 (B317) which corresponds to COM and car-
bapatite deposits in a grafted kidney. Another cause of
hyperoxaluria is bariatric surgery, as shown in Fig. 6, where
COM crystallites may form poorly organized platelets in
tubular lumens. In other cases, some ectopic COM calciﬁ-
cations are made of an agglomeration of COM platelets
with a concentric distribution (Fig. 7). Such diversity may
be, at least in part, related to the location of deposits, most
of them being observed in the lumen of tubules while
Fig. 2. (A) Spatial distribution of COM deposits as given by the intensity of the infrared spectrum at 780 cm1 for different biopsies. (A) Primary hyperoxaluria
(B274); (B) Ethylene glycol poisoning (B292); (C) Cystic ﬁbrosis (B364); (D) Bariatric surgery (B379), (F) and (G) Nephrocalcinosis after kidney transplantation
(B305 and B317); (H,J) infrared spectra of biopsy B317: (H) Infrared spectrum of COM deposit located by the red cross in ﬁgure (G), (J) Infrared spectrum of calcium
phosphate present in some parts of the biopsy as a mixture of carbapatite (CA) and amorphous carbonated calcium phosphate (ACCP) deposits located by the red
cross in ﬁgure (I); (I) Spatial distribution of CA þ ACCP deposits as given by the intensity of the infrared spectrum at 1030 cm1 for biopsy B317.
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Fig. 3. (A) Spatial distribution of COM deposits in biopsy B274 as given by the intensity of the infrared spectrum at 780 cm1 and the topology of the different
abnormal deposits. (B) Topology of the different abnormal deposits for the biopsy B274. (C, E) Radial agglomeration of COM platelets and (D) agglomeration of
platelets.
Fig. 4. A: Topology of the different abnormal deposits in the biopsy B292. Agglomeration of “large” crystallites is observed in the lumen of tubules (C) while
agglomeration of “small” crystallites is located in the tubular cells (B). (D) Radial agglomeration of platelets.
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Fig. 5. A: Topology of the different abnormal deposits for the biopsy B317. B: The red star corresponds to the deposit of CA. C: Presence of numerous holes on the
surface of a compact agglomeration of crystallites.
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size of crystallites seems to be small for deposits within
cells by comparison to deposits accumulated in the tubular
lumen where a radiating organization of the crystallites isFig. 6. A: Topology of the different abnormal deposits at different magni-
ﬁcations for the biopsy B379. B and C agglomeration of “large” and “small”
crystallites.often encountered (Figs. 5 and 8). In the case of biopsy
B274, very different topologies may be observed (Fig. 9).
Another cause for the diversity in the morphology of the
deposits is the chemical composition. Fig. 5 shows various
images of deposits of biopsy B317; Fig. 5C corresponds to
calcium oxalate deposits while Fig. 5B corresponds to cal-
cium phosphate plugs in the tubular lumen.
From a chemical point of view, it is well known that
adsorption of molecules at the crystal surface may modify
the crystal‘s morphology [68e71]. In Fig. 10, typical syn-
thetic COM crystals are shown for which the crystallo-
graphic face has been indicated through their miller indices
[72]. Adsorption of somemolecules (here peptides) leads to
the formation of a “smooth” apical tip. Suchmodiﬁcation of
the morphology is well known, adsorption of molecules is
preferentially observed on undercoordinated atoms of
corners, ridges, or faces leading to their eventual recon-
struction and formation of new faces which will determine
the ﬁnal exposure of these new faces and thus the crys-
tallite's morphology in the native solution. Note that some
anionic surfactants, however, not only changed the crystal
shape, but also induced the formation of metastable cal-
cium oxalate dihydrate (COD) with increasing surfactant
concentration [68].
Similar results have been obtained by A. Okada et al.
[73]. These authors investigated the possible role of a
particular protein, osteopontin (OPN), a major component
of the kidney calcium-containing stone matrix in the
crystallite morphology. To attain this goal, a comparison
between wildtype and OPN knockout mice was performed.
Fig. 7. A: Kidney biopsy from a patient suffering from stomach cancer (B380). Topology of the different abnormal deposits at different magniﬁcations for the
biopsy B380. B: Concentric agglomeration of platelets. C: Agglomeration of very small crystallites.
Fig. 8. A1 and A2: Nephrocalcinosis after kidney transplantation (B386). B and C: Topology of the different abnormal deposits at different magniﬁcations for the
biopsy B386. B: agglomeration of platelets C: Radial organization of platelets.
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Fig. 9. Diversity of the crystallite morphologies observed for the different biopsies.
Fig. 10. (A) Control crystals exhibit an elongated hexagonal platelet
morphology with basal {100} surfaces bounded by {010} and {121} sides. (B)
COM crystals prepared with peptide D4 exhibit a higher length-to-width
aspect ratio. Several peptides in the library also induced rounding of the
D. Bazin et al. / C. R. Chimie 19 (2016) 1548e1557 1555As we can see in Fig. 11, signiﬁcant differences existed be-
tween large rosette and radial shaped crystals observed in
WTmouse kidney (Fig. 11A) and small and uniform crystals
observed in the OPN KOmouse (Fig. 11B). Thus, OPN plays a
crucial role in the morphological organization of COM
crystals in mouse kidneys.
These examples show that the biochemical environ-
ment of calcium oxalate crystallites plays a major role
regarding their morphology. In Table 2, we have tried to
gather the different morphologies pointed by FE-SEM
observations.
From a physiological point of view, many kinds of ion
and molecule exchange processes exist along the nephron.
These exchanges imply that the biochemical environment
varies signiﬁcantly between the proximal tubule, the
Henle's loop, the distal tubule and the collecting duct. For
example, as underlined by P.S. Aronson [74], the reab-
sorption of NaCl in the proximal tubule occurs passively
through the paracellular pathway, and actively by a
transcellular route. Moreover, although short in length, the
distal convoluted tubule plays a critical role in sodium,
potassium, and divalent cation homeostasis [75]. These
changes in the biological environment along the nephron
may have a signiﬁcant effect on the morphology of crystals
and aggregates of calcium oxalate. If one wants to establisha relationship between the COM crystallite morphology
and the nature of hyperoxaluria, we have to combine this
mFTIR e SEM investigation with immunostaining pro-
cedures to distinguish between the different parts of the
nephron.apical tip (arrow in B).
Fig. 11. Polarized light optical microscopy showed large rosette and radial shaped crystals in WT mouse kidney (A) and small and uniform crystals in the kidney
of OPN KO mouse (B). (Adapted from [73]).
Table 2
Morphology of abnormal deposit of COM for the different kidney biopsies
selected for this investigation.
Sample Etiology Morphology of abnormal deposit of COM
B274 Primary
Hyperoxaluria
Agglomeration of platelets with radial
organization of platelets
B292 Ethylene glycol Agglomeration of “large” crystallites
observed in the lumen of tubules,
agglomeration of “small” crystallites
located in the tubular cells and radial
agglomeration of platelets.
B317 Nephrocalcinosis Loose agglomerate of small crystallites
B379 Bariatric surgery Agglomeration of “large” and “small”
crystallites
B380 Stomach cancer Concentric agglomeration of radial
platelets or agglomeration of very
small crystallites
B386 Nephrocalcinosis Agglomeration of platelets with or
without radial organization of platelets
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In order to establish a possible relationship between the
morphology of COM crystallite present in kidney biopsy
and the nature of hyperoxaluria, a mFTIR-SEM investigation
has been performed. The complete set of data allows us to
gather information for the ﬁrst time on the physico-
chemistry of the ectopic calciﬁcations on a set of human
biopsies. First, even in the case of hyperoxaluria, deposits
made of calcium phosphate can be present. Such chemical
diversity calls for a characterization through physico-
chemical techniques like FTIR microspectroscopy for a
more accurate diagnosis of the factors involved in crystal-
lization. Moreover, even if the number of kidney biopsies
included in this series is low, we have shown a diversity in
the crystallite morphology, even for the very same biopsy.
Various factors may be involved in such diversity including
the precise location of the crystals, the presence of com-
pounds able to modulate crystallization, and likely the
composition of the ﬂuid in the tubule depending on the
segment of the nephron where the crystals are found.
Further studies combining mFTIR-SEM investigation andimmunostainings speciﬁc for the different segments of the
nephron would allow one to analyze more thoroughly
intratubular calciﬁcations topography. Finally, we would
like to underline that there is an opportunity to charac-
terize the proteins present on the surface of COM nano-
crystals through nano-FTIR [76e78].
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